Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Cancer Cell|November 4, 2008
H3K79 methylation profiles define murine and human MLL-AF4 leukemiasAndrei V Krivtsov, Zhaohui Feng, Madeleine E Lemieux, et al.Blood|January 31, 2013
Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1lAniruddha J Deshpande, Liying Chen, Maurizio Fazio, et al.Nature|March 6, 2012
Chromatin-modifying enzymes as modulators of reprogrammingTamer T Onder, Nergis Kara, Anne Cherry, et al.Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitorsT Su, Y Wu, B Doughan, et al.Cancer Cell|July 12, 2011
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1LKathrin M Bernt, Nan Zhu, Amit U Sinha, et al.The Journal of Clinical Investigation|March 2, 2016
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemiaSimone S Riedel, Jessica N Haladyna, Matthew Bezzant, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1Przemyslaw Juszczynski, Scott J Rodig, Jing Ouyang, et al.Cell Stem Cell|September 11, 2012
mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesisDemetrios Kalaitzidis, Stephen M Sykes, Zhu Wang, et al.Nature Communications|March 26, 2014
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemiaBrenton G Mar, Lars B Bullinger, Kathleen M McLean, et al.The Journal of Clinical Investigation|February 16, 2016
MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1CNan Zhu, Mo Chen, Rowena Eng, et al.Pageof 10